Zymeworks terminates shareholder rights plan; eliminates Series B Preferred Stock

Zymeworks Inc.

Preferred stock purchase rights under Rights Agreement expired on June 8, 2023, terminating the plan.
Certificate of Elimination filed June 12, 2023 eliminates Series B Participating Preferred Stock.
Series B Preferred shares revert to authorized but unissued preferred stock.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Zymeworks Inc.: The Company filed a Certificate of Elimination to eliminate its Series B Participating Preferred Stock, effective upon filing on June 12, 2023, following the termination of the Rights Agreement (effective 2023-06-12).

Change: charter amendment
Effective: 2023-06-12

Exact text from the filing

the Company filed a Certificate of Elimination with the Secretary of State of the State of Delaware on June 12, 2023, which, effective upon filing, eliminated the Company’s Series B Participating Preferred Stock, par value $0.00001 per share (the “Series B Preferred Stock”).

View on SEC.gov

12 governance changes filed in the last 30 days. Browse all governance changes →

Zymeworks Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-165284

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.